These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 34095308)
1. Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies. Majeed A; Hussain W; Yasmin F; Akhtar A; Rasool N Biomed Res Int; 2021; 2021():6661191. PubMed ID: 34095308 [TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19. Kumar Tiwari P; Chouhan M; Mishra R; Gupta S; Chaudhary AA; Al-Zharani M; Ahmed Qurtam A; Nasr FA; Jha NK; Pant K; Kumar M; Kumar S Front Cell Infect Microbiol; 2024; 14():1391288. PubMed ID: 38919703 [TBL] [Abstract][Full Text] [Related]
3. Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing. Aloufi BH; Snoussi M; Sulieman AME Molecules; 2022 Apr; 27(8):. PubMed ID: 35458599 [TBL] [Abstract][Full Text] [Related]
5. Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations. Kousar K; Majeed A; Yasmin F; Hussain W; Rasool N Biomed Res Int; 2020; 2020():6237160. PubMed ID: 33102585 [TBL] [Abstract][Full Text] [Related]
6. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Vardhan S; Sahoo SK Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of phytoconstituents of Choudhary P; Singh T; Amod A; Singh S J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486 [TBL] [Abstract][Full Text] [Related]
8. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies. Azeem M; Mustafa G; Mahrosh HS Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514 [TBL] [Abstract][Full Text] [Related]
9. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151 [TBL] [Abstract][Full Text] [Related]
10. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616 [TBL] [Abstract][Full Text] [Related]
11. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach. Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973 [TBL] [Abstract][Full Text] [Related]
14. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
15. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics. Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103 [TBL] [Abstract][Full Text] [Related]
16. Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA. Cobre AF; Maia Neto M; de Melo EB; Fachi MM; Ferreira LM; Tonin FS; Pontarolo R J Biomol Struct Dyn; 2024 Jul; 42(11):5881-5894. PubMed ID: 37394802 [TBL] [Abstract][Full Text] [Related]
17. The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets. Parida PK; Paul D; Chakravorty D Phytother Res; 2020 Dec; 34(12):3420-3433. PubMed ID: 32969524 [TBL] [Abstract][Full Text] [Related]
18. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Adem Ş; Eyupoglu V; Sarfraz I; Rasul A; Zahoor AF; Ali M; Abdalla M; Ibrahim IM; Elfiky AA Phytomedicine; 2021 May; 85():153310. PubMed ID: 32948420 [TBL] [Abstract][Full Text] [Related]
19. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. Chandel V; Sharma PP; Raj S; Choudhari R; Rathi B; Kumar D J Biomol Struct Dyn; 2022 Jan; 40(1):249-262. PubMed ID: 32838660 [TBL] [Abstract][Full Text] [Related]
20. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection. Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]